Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1
- 19 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (4), 509-516
- https://doi.org/10.1097/qad.0b013e32801424d2
Abstract
Previous studies on the operational effectiveness of programmes to reduce transmission of HIV from mother-to-child (PMTCT) in Africa have generally been hospital-based pilot studies with short follow-up periods. Prospective cohort study to evaluate the routine operational effectiveness of the South African National PMTCT Programme, primarily measured by HIV-free survival at 36 weeks post-delivery. Three of eighteen pilot sites participating in the programme were selected as they reflected differences in circumstances, such as HIV prevalence, socioeconomic status and rural-urban location. A total of 665 HIV-positive mothers and their infants were followed. HIV-free survival at 36 weeks varied significantly across sites with 84% in Paarl, 74% in Umlazi and 65% in Rietvlei (P = 0.0003). Maternal viral load was the single most important factor associated with HIV transmission or death [hazard ratio (HR), 1.54; 95% confidence interval (CI), 1.21-1.95]. Adjusting for health system variables (fewer than four antenatal visits and no antenatal syphilis test) explained the difference between Rietvlei and Paarl (crude HR, 2.27; 95% CI, 1.36-3.77; adjusted HR, 1.81; 95% CI, 0.93-3.50). Exposure to breastmilk feeding explained the difference between Umlazi and Paarl (crude HR, 1.74; 95% CI, 1.06-2.84; adjusted HR, 1.41; 95% CI, 0.81-2.48). Ever breastfeeding and underlying inequities in healthcare quality within South Africa are predictors of PMTCT programme performance and will need to be addressed to optimize PMTCT effectiveness.Keywords
This publication has 18 references indexed in Scilit:
- Integrating Prevention of Mother-to-Child HIV Transmission Into Routine Antenatal CareJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Preventing Mother-to-Child Transmission of HIV in Western KenyaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, ZambiaAIDS, 2005
- HIV and Mortality of Mothers and ChildrenEpidemiology, 2005
- Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural ZimbabweBMJ, 2004
- Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situationAIDS, 2004
- Estimating the Efficacy of Interventions to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus in Breastfeeding Populations: Comparing Statistical MethodsAmerican Journal of Epidemiology, 2003
- A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 2003
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994